GB1340921A - Pharmaceutical composition - Google Patents
Pharmaceutical compositionInfo
- Publication number
- GB1340921A GB1340921A GB1938771A GB1938771A GB1340921A GB 1340921 A GB1340921 A GB 1340921A GB 1938771 A GB1938771 A GB 1938771A GB 1938771 A GB1938771 A GB 1938771A GB 1340921 A GB1340921 A GB 1340921A
- Authority
- GB
- United Kingdom
- Prior art keywords
- particles
- active substance
- physiologically active
- tablet
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000002245 particle Substances 0.000 abstract 6
- 239000013543 active substance Substances 0.000 abstract 5
- 239000011248 coating agent Substances 0.000 abstract 5
- 238000000576 coating method Methods 0.000 abstract 5
- 239000000203 mixture Substances 0.000 abstract 5
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 abstract 4
- 239000006187 pill Substances 0.000 abstract 4
- 239000012815 thermoplastic material Substances 0.000 abstract 4
- 239000000463 material Substances 0.000 abstract 3
- 239000011159 matrix material Substances 0.000 abstract 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 abstract 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 abstract 2
- 230000001427 coherent effect Effects 0.000 abstract 2
- BOCUKUHCLICSIY-QJWLJZLASA-N cyclothiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(S(N2)(=O)=O)=C1NC2C1[C@H](C=C2)C[C@H]2C1 BOCUKUHCLICSIY-QJWLJZLASA-N 0.000 abstract 2
- 229960003176 cyclothiazide Drugs 0.000 abstract 2
- 239000002934 diuretic Substances 0.000 abstract 2
- 230000001882 diuretic effect Effects 0.000 abstract 2
- 239000006186 oral dosage form Substances 0.000 abstract 2
- 239000001103 potassium chloride Substances 0.000 abstract 2
- 235000011164 potassium chloride Nutrition 0.000 abstract 2
- 238000013268 sustained release Methods 0.000 abstract 2
- 239000012730 sustained-release form Substances 0.000 abstract 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 abstract 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 abstract 1
- 235000019270 ammonium chloride Nutrition 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 230000001754 anti-pyretic effect Effects 0.000 abstract 1
- 239000002221 antipyretic Substances 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 235000013869 carnauba wax Nutrition 0.000 abstract 1
- 239000004203 carnauba wax Substances 0.000 abstract 1
- 239000004359 castor oil Substances 0.000 abstract 1
- 235000019438 castor oil Nutrition 0.000 abstract 1
- 229960000541 cetyl alcohol Drugs 0.000 abstract 1
- 235000003891 ferrous sulphate Nutrition 0.000 abstract 1
- 239000011790 ferrous sulphate Substances 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 abstract 1
- 229940096898 glyceryl palmitate Drugs 0.000 abstract 1
- 229940075529 glyceryl stearate Drugs 0.000 abstract 1
- 238000010438 heat treatment Methods 0.000 abstract 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 abstract 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 abstract 1
- 229910017053 inorganic salt Inorganic materials 0.000 abstract 1
- 229960003511 macrogol Drugs 0.000 abstract 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 abstract 1
- 235000019341 magnesium sulphate Nutrition 0.000 abstract 1
- 238000002844 melting Methods 0.000 abstract 1
- 230000008018 melting Effects 0.000 abstract 1
- 238000002156 mixing Methods 0.000 abstract 1
- 239000012188 paraffin wax Substances 0.000 abstract 1
- 239000011148 porous material Substances 0.000 abstract 1
- 229920002050 silicone resin Polymers 0.000 abstract 1
- 238000005245 sintering Methods 0.000 abstract 1
- 229940084106 spermaceti Drugs 0.000 abstract 1
- 239000012177 spermaceti Substances 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
- 150000003722 vitamin derivatives Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK296670A DK123806B (da) | 1970-06-08 | 1970-06-08 | Fremgangsmåde til fremstilling af tabletter eller piller med langsom afgivelse af et aktivt stof. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1340921A true GB1340921A (en) | 1973-12-19 |
Family
ID=8117638
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1938771A Expired GB1340921A (en) | 1970-06-08 | 1971-06-08 | Pharmaceutical composition |
Country Status (5)
| Country | Link |
|---|---|
| CA (1) | CA944692A (enExample) |
| DE (1) | DE2128527A1 (enExample) |
| DK (1) | DK123806B (enExample) |
| GB (1) | GB1340921A (enExample) |
| SE (1) | SE376720B (enExample) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU600712B2 (en) * | 1986-04-01 | 1990-08-23 | Boehringer Ingelheim International Gmbh | Pellet-containing pharmaceutical compositions |
| WO1992001446A1 (en) * | 1990-07-20 | 1992-02-06 | Aps Research Limited | Sustained-release formulations |
| EP1123699A3 (en) * | 2000-02-11 | 2003-01-22 | McNEIL-PPC, INC. | Tablet and process for making the same |
| FR2991867A1 (fr) * | 2012-06-19 | 2013-12-20 | Cyrille Andres | Dispositif diffuseur de substances pharmacologiquement actives pour un implant orthopedique |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE418247B (sv) * | 1975-11-17 | 1981-05-18 | Haessle Ab | Sett att framstella kroppar med reglerad frigoring av en aktiv komponent |
| DE102009019268A1 (de) | 2009-04-28 | 2010-11-11 | Lts Lohmann Therapie-Systeme Ag | Arzneimittel mit poröser Matrix |
-
1970
- 1970-06-08 DK DK296670A patent/DK123806B/da unknown
-
1971
- 1971-06-03 CA CA114,698A patent/CA944692A/en not_active Expired
- 1971-06-07 SE SE738171A patent/SE376720B/xx unknown
- 1971-06-08 GB GB1938771A patent/GB1340921A/en not_active Expired
- 1971-06-08 DE DE19712128527 patent/DE2128527A1/de active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU600712B2 (en) * | 1986-04-01 | 1990-08-23 | Boehringer Ingelheim International Gmbh | Pellet-containing pharmaceutical compositions |
| WO1992001446A1 (en) * | 1990-07-20 | 1992-02-06 | Aps Research Limited | Sustained-release formulations |
| EP1123699A3 (en) * | 2000-02-11 | 2003-01-22 | McNEIL-PPC, INC. | Tablet and process for making the same |
| FR2991867A1 (fr) * | 2012-06-19 | 2013-12-20 | Cyrille Andres | Dispositif diffuseur de substances pharmacologiquement actives pour un implant orthopedique |
Also Published As
| Publication number | Publication date |
|---|---|
| DK123806B (da) | 1972-08-07 |
| DK123806C (enExample) | 1975-04-07 |
| CA944692A (en) | 1974-04-02 |
| SE376720B (enExample) | 1975-06-09 |
| DE2128527A1 (de) | 1971-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3344029A (en) | Sustained release composition | |
| US3048526A (en) | Medicinal tablet | |
| US3146169A (en) | Pharmaceutical formulations and their manufacture | |
| DE3067536D1 (en) | Powdery pharmaceutical composition and powdery preparation for application to the nasal mucosa, and method for administration thereof | |
| US3632778A (en) | Tablets containing l-dopa | |
| UA49952C2 (uk) | Спосіб виготовлення твердих медикаментозних форм з регульованою віддачею ефективної речовини для перорального застосування та тверда медикаментозна форма | |
| KR930700166A (ko) | 생활성 화합물의 방출을 위한 바이오 세라믹 시스템 | |
| AU5465186A (en) | Devices for the controlled release of active substances, as well as process for the preparation thereof | |
| HK48392A (en) | Drug particles having constant release and immediate release | |
| RU2001113686A (ru) | Применение модафинила и способ получения фармацевтической композиции | |
| ES8307095A1 (es) | Un procedimiento para la estabilizacion de una composicion farmaceutica de trihidrato de amoxicilina y de clavulanato depotasio. | |
| GB1310594A (en) | Antidepressant compositions and dosage units | |
| KR830005854A (ko) | 알카리성 진통제 캡슐의 제조방법 | |
| CA2045680A1 (en) | High ibuprofen content granulations | |
| IL81045A (en) | Pharmaceutical product for the sustained release of ibuprofen and its preparation | |
| IE36335B1 (en) | Layered bolus for animal husbandry providing for immediate and sustained release of medicament | |
| GB1340921A (en) | Pharmaceutical composition | |
| GB1492687A (en) | Water-soluble lubricant in tabletting compositions | |
| GB1022171A (en) | Prolonged release oral pharmaceutical tablets and their manufacture | |
| JPH069382A (ja) | 安定化された固型製剤およびその製造方法 | |
| US5922342A (en) | Lateral edge coated controlled release pharmaceutical compositions | |
| DE3372578D1 (en) | Compressed pills with retarded liberation of active material, and process for their preparation | |
| Schwartz et al. | Intragranular starch: Comparison of starch USP and modified cornstarch | |
| EP0551292B1 (en) | Lateral edge coated controlled release pharmaceutical compositions | |
| ES332215A1 (es) | Un metodo para elaborar tabletas farmaceuticas de libera- cion lenta. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| PLNP | Patent lapsed through nonpayment of renewal fees |